These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26779019)

  • 1. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.
    Toth PP; Patti AM; Nikolic D; Giglio RV; Castellino G; Biancucci T; Geraci F; David S; Montalto G; Rizvi A; Rizzo M
    Front Pharmacol; 2015; 6():299. PubMed ID: 26779019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.
    Nikolic D; Giglio RV; Rizvi AA; Patti AM; Montalto G; Maranta F; Cianflone D; Stoian AP; Rizzo M
    Diabetes Ther; 2021 Jan; 12(1):261-274. PubMed ID: 33210276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Bergamot (Citrus bergamia Risso & Poiteau) Juice in Rats Fed with High-Fat Diet.
    De Leo M; Piragine E; Pirone A; Braca A; Pistelli L; Calderone V; Miragliotta V; Testai L
    Planta Med; 2020 Feb; 86(3):180-189. PubMed ID: 31860116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bergamot on lipid profile in humans: A systematic review.
    Lamiquiz-Moneo I; Giné-González J; Alisente S; Bea AM; Pérez-Calahorra S; Marco-Benedí V; Baila-Rueda L; Jarauta E; Cenarro A; Civeira F; Mateo-Gallego R
    Crit Rev Food Sci Nutr; 2020; 60(18):3133-3143. PubMed ID: 31670973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bergamot (
    Giuffrè AM
    Antioxidants (Basel); 2019 Jul; 8(7):. PubMed ID: 31336933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents.
    Rodríguez-Mortera R; Luevano-Contreras C; Solorio-Meza S; Caccavello R; Bains Y; Garay-Sevilla ME; Gugliucci A
    Clin Chem Lab Med; 2018 Jun; 56(7):1100-1108. PubMed ID: 29447114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
    van Tits LJ; Smilde TJ; van Wissen S; de Graaf J; Kastelein JJ; Stalenhoef AF
    J Investig Med; 2004 Apr; 52(3):177-84. PubMed ID: 15222407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring antioxidants by coulometry: Quantitative assessment of the strikingly high antioxidant capacity of bergamot (Citrus bergamia R.) by-products.
    Siano F; Picariello G; Castaldo D; Cautela D; Caruso T; Vasca E
    Talanta; 2023 Jan; 251():123765. PubMed ID: 35931010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial.
    Fogacci F; Di Micoli V; Veronesi M; Cicero AFG
    Arch Med Sci; 2023; 19(5):1180-1185. PubMed ID: 37732027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients.
    Baldassarre D; Tremoli E; Franceschini G; Michelagnoli S; Sirtori CR
    Stroke; 1996 Jun; 27(6):1044-9. PubMed ID: 8650712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study.
    Ansquer JC; Bekaert I; Guy M; Hanefeld M; Simon A;
    Am J Cardiovasc Drugs; 2009; 9(2):91-101. PubMed ID: 19331437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on low-density lipoprotein subpopulations and comparison between indicators of plasma atherogenicity: a pilot study.
    Kucera M; Oravec S; Hirnerova E; Huckova N; Celecova Z; Gaspar L; Banach M
    Angiology; 2014 Oct; 65(9):794-9. PubMed ID: 24163116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.